Mihail G. Chelu, MD, PhD (@MihailChelu) header
Mihail G. Chelu, MD, PhD (@MihailChelu) profile picture

Physician-scientist | Professor | Director Research @Texas_Heart @BCMHouston | co-PI with @KennethEllenbo1 of @leftvsleft RCT

Houston, TX
Joined November 2015
Photo by Mihail G. Chelu, MD, PhD (@MihailChelu)Photo by Mihail G. Chelu, MD, PhD (@MihailChelu)Photo by Mihail G. Chelu, MD, PhD (@MihailChelu)Photo by Mihail G. Chelu, MD, PhD (@MihailChelu)Photo by Mihail G. Chelu, MD, PhD (@MihailChelu)Photo by Mihail G. Chelu, MD, PhD (@MihailChelu)Photo by Mihail G. Chelu, MD, PhD (@MihailChelu)Photo by Mihail G. Chelu, MD, PhD (@MihailChelu)Photo by Mihail G. Chelu, MD, PhD (@MihailChelu)Photo by Mihail G. Chelu, MD, PhD (@MihailChelu)
Mihail G. Chelu, MD, PhD retweeted
pdated meta-analysis of LAAC vs AC: poten ally increased ischemic stroke with LAAC although the overall risk remains low in contemporary prac ce @AnneBCurtis @MihailChelu @CaiqueTernesMD #Epeeps ahajrnls.org/4jsPpMQ
2
4
589
Mihail G. Chelu, MD, PhD retweeted
Getting it wrong for many decades. Since the 1950's, pacemaker leads have been placed in the right ventricle. A new randomized trial challenging that dogma found marked superiority of outcomes for pacing from the left bundle branch. nejm.org/doi/full/10.1056/NE…
18
84
6
346
50,853
Mihail G. Chelu, MD, PhD retweeted
#ConductionSystemPacing is safe and feasible in children. First large, international multicenter registry with mid-term follow-up (24 months) focused on the pediatric population, which can also benefit from physiological pacing authors.elsevier.com/a/1o3SH… #LBBAP #EPeeps
2
18
35
1,935
Mihail G. Chelu, MD, PhD retweeted
Original Article: Left Bundle-Branch Pacing versus Right Ventricular Pacing for Atrioventricular Block (OptimPacing trial) nej.md/4favsI9 #ScientificSessions26 | @AHAScience
3
16
2
56
14,348
Mihail G. Chelu, MD, PhD retweeted
Presented at #ScientificSessions26: In patients with atrioventricular block, left bundle-branch pacing resulted in a lower incidence of a composite of death, hospitalization for heart failure, or pacing-induced cardiomyopathy than right ventricular pacing. Full OptimPacing trial results: nej.md/4favsI9 @AHAScience
8
147
19
391
68,921
Mihail G. Chelu, MD, PhD retweeted
PPS 10th edition started at lovely @UChicago campus with talks from @Marek_Jastrz_EP @DrRoderickTung and @ZacharyWhinnett on role of ECG, EP study and invasive mapping on assessment of LBBAP. @gauravaupadhyay @GDandamudiMD @pvijayaraman1 – at Chicago, IL
1
10
1
31
3,627
Mihail G. Chelu, MD, PhD retweeted
La electrofisiología de Latinoamérica se reúne en la Ciudad de México 🫀 Del 18 al 20 de noviembre vive el Congreso Internacional LAHRS – SOMEEC 2026 en el Hilton Reforma: tres días de ciencia, casos en vivo y expertos de todo el mundo #LAHRS2026 lahrssomeec2026.com
9
1
17
1,755
Mihail G. Chelu, MD, PhD retweeted
The #HRS2027 Call for Science is open! 🔬 Add your work to the year’s biggest EP science: 1,800+ abstracts, 1,600+ posters, 200+ sessions, 10,000+ heart rhythm professionals. 📄 Submit your research by Dec 16: bit.ly/4yUyWXj 🙋‍♀ Want to shape the program another way? Volunteer to review submissions by Nov 15: bit.ly/3VP9PGL Program Chair: @JagSinghMD Abstract Chair: Christopher Liu, MD, FHRS Program Committee: @MDTolgaAksu @Mel_Gunawardene @aymanhusseinmd @MoussaMansour10 @nmarrouche @DrSrivatsa @Vortexium32 @Nchatterjeemd @MaggieInfeld @rdschaller @dredcronin @DanielAlyeshmer @BadhwarNitish @MihailChelu @rajeshkabramd @PamelaMasonEP @PassmanRod @HamidGhanbariMD @raebaba @JonathanAriya @SergioPinski @swatirao24 @DrSanatani @aronismd @MaullyShah @Kantharia_EP
3
2
7
1,538
Mihail G. Chelu, MD, PhD retweeted
NEK7 activates the NLRP3 inflammasome in atrial cardiomyocytes and contributes to postoperative AF, constituting a potential therapeutic target for AF @naliphd #Epeeps doi.org/10.1161/CIRCEP.126.0…
4
6
1,094
The 10th Annual Physiology of Pacing Symposium (#PPS10) is right around the corner! Reminder to fellows to submit their science (300 word abstract, up to 2 figures) for our abstract competition by October 1, 2026 to [email protected]. cvent.me/XmZMW9
8
4
18
9,317
Mihail G. Chelu, MD, PhD retweeted
The HIS Alternative II study is now available in JACC-EP: kwnsfk27.r.eu-west-1.awstrac…
2
3
2
12
3,417
Mihail G. Chelu, MD, PhD retweeted
Celebrating 10y🎖️at the forefront of Conduction System Pacing Nov 6 • Live procedural broadcasts • Breakthrough clinical trial data • Actionable strategies for CSP implementation Don’t miss this milestone event! cvent.me/XmZMW9 @gauravaupadhyay @DrRoderickTung
#PPS10 PHYSIOLOGY OF PACING SYMPOSIUM 10th Anniversary ⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️💜 Wait is over; registration 📥for the biggest and best event of the year in Cond. Syst. Pacing 🌿 @gauravaupadhyay @DrRoderickTung @KennethEllenbo1 @pvijayaraman1 @GDandamudiMD cvent.me/XmZMW9
1
7
1
19
2,692
Excited to welcome you this Fall to Chicago and the 10th Annual Physiology of Pacing Symposium (#PPS10)! Join us where the #physiologicalpacing movement took off! cvent.me/XmZMW9 @DrRoderickTung @KennethEllenbo1 @Hisdoc1 @GDandamudiMD #EPeeps #HRS #HRSSynchronicity
3
10
1
21
6,446
Excited to share our newest publication in @JACCJournals from Chelu & @naliphd Labs! 👏Congrats to Tingting Li for leading this work! We show LMNA deficiency causes progressive AV block, with SK3 dysfunction as a novel mechanism and therapeutic target. authors.elsevier.com/a/1nZoN…
2
1
9
2,876
Mihail G. Chelu, MD, PhD retweeted
Enrollment in HIS-CRT is complete! This milestone would not have been possible without the dedication of our site investigators, study coordinators, and most importantly, the participants. #HISCRT #ClinicalTrials #Cardiology #HeartFailure #ClinicalResearch
5
22
1,424
Mihail G. Chelu, MD, PhD retweeted
#PPS10 PHYSIOLOGY OF PACING SYMPOSIUM 10th Anniversary ⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️⭐️💜 Wait is over; registration 📥for the biggest and best event of the year in Cond. Syst. Pacing 🌿 @gauravaupadhyay @DrRoderickTung @KennethEllenbo1 @pvijayaraman1 @GDandamudiMD cvent.me/XmZMW9
1
10
3
28
8,343
Mihail G. Chelu, MD, PhD retweeted
NEW EPISODE OF THE LEAD! [Ep. 146] A Discussion of LEAP2: A First-In-Human Study of a Chronically-Implanted Novel Leadless Pacemaker for Conduction System Pacing 🎙️ Host: Christopher C Cheung, MD, MPH, FHRS (@ChrisCheungMD) 🎤 Guests: Derek Chew, MD, MS, FHRS (@derek_c1) and Mihail G. Chelu, MD, PhD, FHRS (@MihailChelu) Listen on your preferred podcast platform ➡️ bit.ly/48bpxNn #EPeeps #medpod #podcast #CardioTwitter #EPTwitter #PodcastAndChill
3
4
855
Mihail G. Chelu, MD, PhD retweeted
#HeartFailure (HF) affects more than 64 million individuals worldwide, and acute HF is associated with 1-year mortality rates of 23.6% in North America and Europe. Cardiac resynchronization therapy restores synchronous ventricular activation in patients with HF, reduced LVEF, and left bundle-branch block, or in those requiring chronic ventricular pacing, and may improve LV function, decrease HF hospitalizations, and reduce mortality. 🧵 🔗 Learn more in this JAMA Review: ja.ma/4tTXfSR
1
101
1
320
21,399
Our lead extraction experience @Texas_Heart and @bcmhouston published online in Cardiovascular Drugs and Therapy. rdcu.be/e86d2
2
231